Global Anti-Obesity Prescription Drugs Professional Survey Report 2022, Forecast to 2027

Code: RW00014817233
Multimarket Insight
Aug-2022
Life Sciences
105 Pages

Anti-obesity medication or weight loss medications are pharmacological agents that reduce or control weight. These medications alter one of the fundamental processes of the human body, weight regulation, by altering either appetite, or absorption of calories.
We aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.

Case numbers are resurging in parts of the world where the COVID-19 pandemic was waning, falling in places that saw huge surges recently, and just beginning to rise in previously little-impacted parts of the globe.
Studying and analyzing the impact of Coronavirus COVID-19 on the Anti-Obesity Prescription Drugs industry, the report provide in-depth analysis and professtional advices on how to face the post COIVD-19 period.

Market Segment by Product Type
Orlistat
Phentermine and Topiramate
Bupropion and Naltrexone
Lorcaserin
Liraglutide

Market Segment by Product Application
Pediatric
Adult

Finally, the report provides detailed profile and data information analysis of leading company.
F Hoffmann La Roche Ltd
Alizyme
Arena Pharmaceuticals
Orexigen Therapeutics
Boehringer Ingelheim
Novo Nordisk A/s
Vivus
Glaxosmithkline

Insights and Tools:
Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.
Product values and regional markets are estimated by market analyst, data analyst and people from related industry, based on companys' revenue and applications market respectively.
The data sources include but not limited to reports of companys,international organizations and governments, MMI market surveys,and related industry news.
Analyses of global market trends, with historical data, estimates for 2022 and projections of compound annual growth rates (CAGRs) through 2027
The market research includes historical and forecast data from like demand, application details, price trends, and company shares by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
In addition, the report provides insight into main drivers,challenges,opportunities and risk of the market and strategies of suppliers. Key players are profiled as well with their market shares in the global market discussed.

Research Objectives
1.To study and analyze the global Anti-Obesity Prescription Drugs consumption (value) by key regions/countries, product type and application, history data from 2017 to 2021, and forecast to 2027.
2.To understand the structure of Anti-Obesity Prescription Drugs market by identifying its various subsegments.
3.Focuses on the key global Anti-Obesity Prescription Drugs manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
4.To analyze the Anti-Obesity Prescription Drugs with respect to individual growth trends, future prospects, and their contribution to the total market.
5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
6.To project the consumption of Anti-Obesity Prescription Drugs submarkets, with respect to key regions (along with their respective key countries).
7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
8.To strategically profile the key players and comprehensively analyze their growth strategies.

Table of Contents

Global Anti-Obesity Prescription Drugs Professional Survey Report Report 2022, Forecast to 2027

1 Market Study Overview
1.1 Study Objectives
1.2 Anti-Obesity Prescription Drugs Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research Methods
1.5 Market Breakdown and Data Triangulation

2 Global Trend Summary
2.1 Anti-Obesity Prescription Drugs Segment by Type
2.1.1 Orlistat
2.1.2 Phentermine and Topiramate
2.1.3 Bupropion and Naltrexone
2.1.4 Lorcaserin
2.1.5 Liraglutide
2.2 Market Analysis by Application
2.2.1 Pediatric
2.2.2 Adult
2.3 Global Anti-Obesity Prescription Drugs Market Comparison by Regions (2017-2027)
2.3.1 Global Anti-Obesity Prescription Drugs Market Size (2017-2027)
2.3.2 North America Anti-Obesity Prescription Drugs Status and Prospect (2017-2027)
2.3.3 Europe Anti-Obesity Prescription Drugs Status and Prospect (2017-2027)
2.3.4 Asia-pacific Anti-Obesity Prescription Drugs Status and Prospect (2017-2027)
2.3.5 South America Anti-Obesity Prescription Drugs Status and Prospect (2017-2027)
2.3.6 Middle East & Africa Anti-Obesity Prescription Drugs Status and Prospect (2017-2027)
2.4 Basic Product Information
2.4.1 Basic Product Information & Technology Development History
2.4.2 Product Manufacturing Process
2.4.3 Interview with Major Market Participants
2.4.4 High-end Market Analysis and Forecast
2.5 Coronavirus Disease 2019 (Covid-19): Anti-Obesity Prescription Drugs Industry Impact
2.5.1 Anti-Obesity Prescription Drugs Business Impact Assessment - Covid-19
2.5.2 Market Trends and Anti-Obesity Prescription Drugs Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19

3 Competition by Manufacturer
3.1 Global Anti-Obesity Prescription Drugs Sales and Market Share by Manufacturer (2017-2022)
3.2 Global Anti-Obesity Prescription Drugs Revenue and Market Share by Manufacturer (2017-2022)
3.3 Global Anti-Obesity Prescription Drugs Industry Concentration Ratio (CR5 and HHI)
3.4 Top 5 Anti-Obesity Prescription Drugs Manufacturer Market Share
3.5 Top 10 Anti-Obesity Prescription Drugs Manufacturer Market Share
3.6 Date of Key Manufacturers Enter into Anti-Obesity Prescription Drugs Market
3.7 Key Manufacturers Anti-Obesity Prescription Drugs Product Offered
3.8 Mergers & Acquisitions Planning

4 Analysis of Anti-Obesity Prescription Drugs Industry Key Manufacturers
4.1 F Hoffmann La Roche Ltd
4.1.1 Company Details
4.1.2 F Hoffmann La Roche Ltd Anti-Obesity Prescription Drugs Product Introduction, Application and Specification
4.1.3 F Hoffmann La Roche Ltd Anti-Obesity Prescription Drugs Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.1.4 Main Business Overview
4.1.5 F Hoffmann La Roche Ltd News
4.2 Alizyme
4.2.1 Company Details
4.2.2 Alizyme Anti-Obesity Prescription Drugs Product Introduction, Application and Specification
4.2.3 Alizyme Anti-Obesity Prescription Drugs Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.2.4 Main Business Overview
4.2.5 Alizyme News
4.3 Arena Pharmaceuticals
4.3.1 Company Details
4.3.2 Arena Pharmaceuticals Anti-Obesity Prescription Drugs Product Introduction, Application and Specification
4.3.3 Arena Pharmaceuticals Anti-Obesity Prescription Drugs Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.3.4 Main Business Overview
4.3.5 Arena Pharmaceuticals News
4.4 Orexigen Therapeutics
4.4.1 Company Details
4.4.2 Orexigen Therapeutics Anti-Obesity Prescription Drugs Product Introduction, Application and Specification
4.4.3 Orexigen Therapeutics Anti-Obesity Prescription Drugs Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.4.4 Main Business Overview
4.4.5 Orexigen Therapeutics News
4.5 Boehringer Ingelheim
4.5.1 Company Details
4.5.2 Boehringer Ingelheim Anti-Obesity Prescription Drugs Product Introduction, Application and Specification
4.5.3 Boehringer Ingelheim Anti-Obesity Prescription Drugs Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.5.4 Main Business Overview
4.5.5 Boehringer Ingelheim News
4.6 Novo Nordisk A/s
4.6.1 Company Details
4.6.2 Novo Nordisk A/s Anti-Obesity Prescription Drugs Product Introduction, Application and Specification
4.6.3 Novo Nordisk A/s Anti-Obesity Prescription Drugs Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.6.4 Main Business Overview
4.6.5 Novo Nordisk A/s News
4.7 Vivus
4.7.1 Company Details
4.7.2 Vivus Anti-Obesity Prescription Drugs Product Introduction, Application and Specification
4.7.3 Vivus Anti-Obesity Prescription Drugs Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.7.4 Main Business Overview
4.7.5 Vivus News
4.8 Glaxosmithkline
4.8.1 Company Details
4.8.2 Glaxosmithkline Anti-Obesity Prescription Drugs Product Introduction, Application and Specification
4.8.3 Glaxosmithkline Anti-Obesity Prescription Drugs Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.8.4 Main Business Overview
4.8.5 Glaxosmithkline News

5 Global Anti-Obesity Prescription Drugs Sales Categorized by Regions
5.1 Global Anti-Obesity Prescription Drugs Revenue, Sales and Market Share by Regions
5.1.1 Global Anti-Obesity Prescription Drugs Sales and Market Share by Regions (2017-2022)
5.1.2 Global Anti-Obesity Prescription Drugs Revenue and Market Share by Regions (2017-2022)
5.2 North America Anti-Obesity Prescription Drugs Sales and Growth Rate (2017-2022)
5.3 Europe Anti-Obesity Prescription Drugs Sales and Growth Rate (2017-2022)
5.4 Asia-pacific Anti-Obesity Prescription Drugs Sales and Growth Rate (2017-2022)
5.5 South America Anti-Obesity Prescription Drugs Sales and Growth Rate (2017-2022)
5.6 Middle East & Africa Anti-Obesity Prescription Drugs Sales and Growth Rate (2017-2022)

6 North America Anti-Obesity Prescription Drugs Market Size Categorized by Countries
6.1 North America Anti-Obesity Prescription Drugs Sales, Revenue and Market Share by Countries
6.1.1 North America Anti-Obesity Prescription Drugs Sales (Volume) by Countries (2017-2022)
6.1.2 North America Anti-Obesity Prescription Drugs Revenue by Countries (2017-2022)
6.1.3 United States Anti-Obesity Prescription Drugs Sales and Growth Rate (2017-2022)
6.1.4 Canada Anti-Obesity Prescription Drugs Sales and Growth Rate (2017-2022)
6.1.5 Mexico Anti-Obesity Prescription Drugs Sales and Growth Rate (2017-2022)
6.2 North America Anti-Obesity Prescription Drugs Revenue (Value) by Manufacturers
6.3 North America Anti-Obesity Prescription Drugs Sales and Market Share by Type (2017-2022)
6.4 North America Anti-Obesity Prescription Drugs Sales Market Share by Application (2017-2022)

7 Europe Anti-Obesity Prescription Drugs Market Size Categorized by Countries
7.1 Europe Anti-Obesity Prescription Drugs Sales, Revenue and Market Share by Countries
7.1.1 Europe Anti-Obesity Prescription Drugs Sales (Volume) by Countries (2017-2022)
7.1.2 Europe Anti-Obesity Prescription Drugs Revenue by Countries (2017-2022)
7.1.3 Germany Anti-Obesity Prescription Drugs Sales and Growth Rate (2017-2022)
7.1.4 UK Anti-Obesity Prescription Drugs Sales and Growth Rate (2017-2022)
7.1.5 France Anti-Obesity Prescription Drugs Sales and Growth Rate (2017-2022)
7.1.6 Russia Anti-Obesity Prescription Drugs Sales and Growth Rate (2017-2022)
7.1.7 Italy Anti-Obesity Prescription Drugs Sales and Growth Rate (2017-2022)
7.1.8 Spain Anti-Obesity Prescription Drugs Sales and Growth Rate (2017-2022)
7.2 Europe Anti-Obesity Prescription Drugs Revenue (Value) by Manufacturers
7.3 Europe Anti-Obesity Prescription Drugs Sales and Market Share by Type (2017-2022)
7.4 Europe Anti-Obesity Prescription Drugs Sales Market Share by Application (2017-2022)

8 Asia-Pacific Anti-Obesity Prescription Drugs Market Size Categorized by Countries
8.1 Asia-pacific Anti-Obesity Prescription Drugs Sales, Revenue and Market Share by Countries
8.1.1 Asia-pacific Anti-Obesity Prescription Drugs Sales (Volume) by Countries (2017-2022)
8.1.2 Asia-pacific Anti-Obesity Prescription Drugs Revenue by Countries (2017-2022)
8.1.3 China Anti-Obesity Prescription Drugs Sales and Growth Rate (2017-2022)
8.1.4 South Korea Anti-Obesity Prescription Drugs Sales and Growth Rate (2017-2022)
8.1.5 Japan Anti-Obesity Prescription Drugs Sales and Growth Rate (2017-2022)
8.1.6 Australia Anti-Obesity Prescription Drugs Sales and Growth Rate (2017-2022)
8.1.7 India Anti-Obesity Prescription Drugs Sales and Growth Rate (2017-2022)
8.1.8 Southeast Asia Anti-Obesity Prescription Drugs Sales and Growth Rate (2017-2022)
8.2 Asia-pacific Anti-Obesity Prescription Drugs Revenue (Value) by Manufacturers
8.3 Asia-pacific Anti-Obesity Prescription Drugs Sales and Market Share by Type (2017-2022)
8.4 Asia-pacific Anti-Obesity Prescription Drugs Sales Market Share by Application (2017-2022)

9 South America Anti-Obesity Prescription Drugs Market Size Categorized by Countries
9.1 South America Anti-Obesity Prescription Drugs Sales, Revenue and Market Share by Countries
9.1.1 South America Anti-Obesity Prescription Drugs Sales (Volume) by Countries (2017-2022)
9.1.2 South America Anti-Obesity Prescription Drugs Revenue by Countries (2017-2022)
9.1.3 Brazil Anti-Obesity Prescription Drugs Sales and Growth Rate (2017-2022)
9.2 South America Anti-Obesity Prescription Drugs Sales and Market Share by Type (2017-2022)
9.3 South America Anti-Obesity Prescription Drugs Sales Market Share by Application (2017-2022)

10 Middle East and Africa Anti-Obesity Prescription Drugs Market Size Categorized by Countries
10.1 Middle East and Africa Anti-Obesity Prescription Drugs Sales, Revenue and Market Share by Countries
10.1.1 Middle East and Africa Anti-Obesity Prescription Drugs Sales (Volume) by Countries (2017-2022)
10.1.2 Middle East and Africa Anti-Obesity Prescription Drugs Revenue by Countries (2017-2022)
10.1.3 GCC Countries Anti-Obesity Prescription Drugs Sales and Growth Rate (2017-2022)
10.1.4 Turkey Anti-Obesity Prescription Drugs Sales and Growth Rate (2017-2022)
10.1.5 Egypt Anti-Obesity Prescription Drugs Sales and Growth Rate (2017-2022)
10.1.6 South America Anti-Obesity Prescription Drugs Sales and Growth Rate (2017-2022)
10.2 Middle East and Africa Anti-Obesity Prescription Drugs Sales and Market Share by Type
10.3 Middle East and Africa Anti-Obesity Prescription Drugs Sales Market Share by Application (2017-2022)

11 Global Anti-Obesity Prescription Drugs Market Segment by Type
11.1 Global Anti-Obesity Prescription Drugs Revenue, Sales and Market Share by Type (2017-2022)
11.1.1 Global Anti-Obesity Prescription Drugs Sales and Market Share by Type (2017-2022)
11.1.2 Global Anti-Obesity Prescription Drugs Revenue and Market Share by Type (2017-2022)
11.2 Orlistat Sales Growth Rate and Price
11.2.1 Global Orlistat Sales Growth Rate (2017-2022)
11.2.2 Global Orlistat Price (2017-2022)
11.3 Phentermine and Topiramate Sales Growth Rate and Price
11.3.1 Global Phentermine and Topiramate Sales Growth Rate (2017-2022)
11.3.2 Global Phentermine and Topiramate Price (2017-2022)
11.4 Bupropion and Naltrexone Sales Growth Rate and Price
11.4.1 Global Bupropion and Naltrexone Sales Growth Rate (2017-2022)
11.4.2 Global Bupropion and Naltrexone Price (2017-2022)
11.5.1 Global Lorcaserin Sales Growth Rate (2017-2022)
11.5.2 Global Lorcaserin Price (2017-2022)
11.6 Liraglutide Sales Growth Rate and Price
11.6.1 Global Liraglutide Sales Growth Rate (2017-2022)
11.6.2 Global Liraglutide Price (2017-2022)

12 Global Anti-Obesity Prescription Drugs Market Segment by Application
12.1 Global Anti-Obesity Prescription Drugs Sales Market Share by Application (2017-2022)
12.2 Pediatric Sales Growth Rate (2017-2022)
12.3 Adult Sales Growth Rate (2017-2022)

13 Global Anti-Obesity Prescription Drugs Market Forecast
13.1 Global Anti-Obesity Prescription Drugs Revenue, Sales and Growth Rate (2022-2027)
13.2 Anti-Obesity Prescription Drugs Market Forecast by Regions (2022-2027)
13.2.1 North America Anti-Obesity Prescription Drugs Market Forecast (2022-2027)
13.2.2 Europe Anti-Obesity Prescription Drugs Market Forecast (2022-2027)
13.2.3 Asia-Pacific Anti-Obesity Prescription Drugs Market Forecast (2022-2027)
13.2.4 South America Anti-Obesity Prescription Drugs Market Forecast (2022-2027)
13.2.5 Middle East & Africa Anti-Obesity Prescription Drugs Market Forecast (2022-2027)
13.3 Anti-Obesity Prescription Drugs Market Forecast by Type (2022-2027)
13.3.1 Global Anti-Obesity Prescription Drugs Sales Forecast by Type (2022-2027)
13.3.2 Global Anti-Obesity Prescription Drugs Market Share Forecast by Type (2022-2027)
13.4 Anti-Obesity Prescription Drugs Market Forecast by Application (2022-2027)
13.4.1 Global Anti-Obesity Prescription Drugs Sales Forecast by Application (2022-2027)
13.4.2 Global Anti-Obesity Prescription Drugs Market Share Forecast by Application (2022-2027)

14 Market Analysis
14.1.1 Market overview
14.1.2 Market Opportunities
14.1.3 Market Risk
14.1.4 Market Driving Force
14.1.5 Porter's Five Forces Analysis
14.1.6 SWOT Analysis

15 Anti-Obesity Prescription Drugs Industry Related Market Analysis
15.1 Upstream Analysis
15.1.1 Macro Analysis of Upstream Markets
15.1.2 Key Players in Upstream Markets
15.1.3 Upstream Market Trend Analysis
15.1.4 Anti-Obesity Prescription Drugs Manufacturing Cost Analysis
15.2 Downstream Market Analysis
15.2.1 Macro Analysis of Down Markets
15.2.2 Key Players in Down Markets
15.2.3 Downstream Market Trend Analysis
15.2.4 Sales Channel, Distributors, Traders and Dealers

List of Tables and Figures

Figure Product Picture Anti-Obesity Prescription Drugs
Figure Market Concentration Ratio and Market Maturity Analysis of Anti-Obesity Prescription Drugs
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Figure Part of Our External Database
Figure Key Executives Interviewed
Table Global Anti-Obesity Prescription Drugs Market Size by Type
Figure Global Market Share of Anti-Obesity Prescription Drugs by Type in 2021
Figure Orlistat Picture
Figure Phentermine and Topiramate Picture
Figure Bupropion and Naltrexone Picture
Figure Lorcaserin Picture
Figure Liraglutide Picture
Table Global Anti-Obesity Prescription Drugs Market Size (Volume) by Application
Figure Pediatric Picture
Figure Adult Picture
Table Global Anti-Obesity Prescription Drugs Comparison by Regions (M USD) 2017-2027
Figure Global Anti-Obesity Prescription Drugs Market Size (Million US$) (2017-2027)
Figure North America Anti-Obesity Prescription Drugs Revenue (Million US$) Growth Rate (2017-2027)
Figure Europe Anti-Obesity Prescription Drugs Revenue (Million US$) Growth Rate (2017-2027)
Figure Asia-pacific Anti-Obesity Prescription Drugs Revenue (Million US$) Growth Rate (2017-2027)
Figure South America Anti-Obesity Prescription Drugs Revenue (Million US$) Growth Rate (2017-2027)
Figure Middle East & Africa Anti-Obesity Prescription Drugs Revenue (Million US$) Growth Rate (2017-2027)
Table Business Impact Assessment - Covid-19
Table Market Trends and Anti-Obesity Prescription Drugs Potential Opportunities in the COVID-19 Landscape
Table Measures / Proposal against Covid-19
Table Global Anti-Obesity Prescription Drugs Sales by Manufacturer (2017-2022)
Figure Global Anti-Obesity Prescription Drugs Sales Market Share by Manufacturer in 2021
Table Global Anti-Obesity Prescription Drugs Revenue by Manufacturer (2017-2022)
Figure Global Anti-Obesity Prescription Drugs Revenue Market Share by Manufacturer in 2021
Table Global Anti-Obesity Prescription Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Anti-Obesity Prescription Drugs Manufacturer (Revenue) Market Share in 2021
Figure Top 10 Anti-Obesity Prescription Drugs Manufacturer (Revenue) Market Share in 2021
Table Date of Key Manufacturers Enter into Anti-Obesity Prescription Drugs Market
Table Key Manufacturers Anti-Obesity Prescription Drugs Product Type
Table Mergers & Acquisitions Planning
Table F Hoffmann La Roche Ltd Company Profile
Table Anti-Obesity Prescription Drugs Product Introduction, Application and Specification of F Hoffmann La Roche Ltd
Table Anti-Obesity Prescription Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of F Hoffmann La Roche Ltd 2017-2022
Table F Hoffmann La Roche Ltd Main Business
Table F Hoffmann La Roche Ltd Recent Development
Table Alizyme Company Profile
Table Anti-Obesity Prescription Drugs Product Introduction, Application and Specification of Alizyme
Table Anti-Obesity Prescription Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Alizyme 2017-2022
Table Alizyme Main Business
Table Alizyme Recent Development
Table Arena Pharmaceuticals Company Profile
Table Anti-Obesity Prescription Drugs Product Introduction, Application and Specification of Arena Pharmaceuticals
Table Anti-Obesity Prescription Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Arena Pharmaceuticals 2017-2022
Table Arena Pharmaceuticals Main Business
Table Arena Pharmaceuticals Recent Development
Table Orexigen Therapeutics Company Profile
Table Anti-Obesity Prescription Drugs Product Introduction, Application and Specification of Orexigen Therapeutics
Table Anti-Obesity Prescription Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Orexigen Therapeutics 2017-2022
Table Orexigen Therapeutics Main Business
Table Orexigen Therapeutics Recent Development
Table Boehringer Ingelheim Company Profile
Table Anti-Obesity Prescription Drugs Product Introduction, Application and Specification of Boehringer Ingelheim
Table Anti-Obesity Prescription Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Boehringer Ingelheim 2017-2022
Table Boehringer Ingelheim Main Business
Table Boehringer Ingelheim Recent Development
Table Novo Nordisk A/s Company Profile
Table Anti-Obesity Prescription Drugs Product Introduction, Application and Specification of Novo Nordisk A/s
Table Anti-Obesity Prescription Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Novo Nordisk A/s 2017-2022
Table Novo Nordisk A/s Main Business
Table Novo Nordisk A/s Recent Development
Table Vivus Company Profile
Table Anti-Obesity Prescription Drugs Product Introduction, Application and Specification of Vivus
Table Anti-Obesity Prescription Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Vivus 2017-2022
Table Vivus Main Business
Table Vivus Recent Development
Table Glaxosmithkline Company Profile
Table Anti-Obesity Prescription Drugs Product Introduction, Application and Specification of Glaxosmithkline
Table Anti-Obesity Prescription Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Glaxosmithkline 2017-2022
Table Glaxosmithkline Main Business
Table Glaxosmithkline Recent Development
Figure Global Anti-Obesity Prescription Drugs Sales and Growth Rate (2017-2022)
Figure Global Anti-Obesity Prescription Drugs Revenue and Growth Rate (2017-2022)
Table Global Anti-Obesity Prescription Drugs Sales by Regions (2017-2022)
Figure Global Anti-Obesity Prescription Drugs Sales Market Share by Regions in 2021
Table Global Anti-Obesity Prescription Drugs Revenue by Regions (2017-2022)
Figure Global Anti-Obesity Prescription Drugs Revenue Market Share by Regions in 2021
Figure North America Anti-Obesity Prescription Drugs Sales and Growth Rate (2017-2022)
Figure Europe Anti-Obesity Prescription Drugs Sales and Growth Rate (2017-2022)
Figure Asia-pacific Anti-Obesity Prescription Drugs Sales and Growth Rate (2017-2022)
Figure South America Anti-Obesity Prescription Drugs Sales and Growth Rate (2017-2022)
Figure Middle East & Africa Anti-Obesity Prescription Drugs Sales and Growth Rate (2017-2022)
Figure North America Anti-Obesity Prescription Drugs Revenue and Growth Rate (2017-2022)
Table North America Anti-Obesity Prescription Drugs Sales (Volume) by Countries (2017-2022)
Table North America Anti-Obesity Prescription Drugs Sales Market Share by Countries (2017-2022)
Figure North America Anti-Obesity Prescription Drugs Sales Market Share by Countries in 2021
Table North America Anti-Obesity Prescription Drugs Revenue by Countries (2017-2022)
Table North America Anti-Obesity Prescription Drugs Revenue Market Share by Countries (2017-2022)
Figure North America Anti-Obesity Prescription Drugs Revenue Market Share by Countries in 2021
Figure United States Anti-Obesity Prescription Drugs Sales and Growth Rate (2017-2022)
Figure Canada Anti-Obesity Prescription Drugs Sales and Growth Rate (2017-2022)
Figure Mexico Anti-Obesity Prescription Drugs Sales and Growth Rate (2017-2022)
Table North America Anti-Obesity Prescription Drugs Revenue by Manufacturer (2021)
Figure North America Anti-Obesity Prescription Drugs Revenue Market Share by Manufacturer in 2021
Table North America Anti-Obesity Prescription Drugs Sales by Type (2017-2022)
Table North America Anti-Obesity Prescription Drugs Sales Share by Type (2017-2022)
Table North America Anti-Obesity Prescription Drugs Sales by Application (2017-2022)
Table North America Anti-Obesity Prescription Drugs Sales Share by Application (2017-2022)
Figure Europe Anti-Obesity Prescription Drugs Revenue and Growth Rate (2017-2022)
Table Europe Anti-Obesity Prescription Drugs Sales (Volume) by Countries (2017-2022)
Table Europe Anti-Obesity Prescription Drugs Sales Market Share by Countries (2017-2022)
Figure Europe Anti-Obesity Prescription Drugs Sales Market Share by Countries in 2021
Table Europe Anti-Obesity Prescription Drugs Revenue by Countries (2017-2022)
Table Europe Anti-Obesity Prescription Drugs Revenue Market Share by Countries (2017-2022)
Figure Europe Anti-Obesity Prescription Drugs Revenue Market Share by Countries in 2021
Figure Germany Anti-Obesity Prescription Drugs Sales and Growth Rate (2017-2022)
Figure UK Anti-Obesity Prescription Drugs Sales and Growth Rate (2017-2022)
Figure France Anti-Obesity Prescription Drugs Sales and Growth Rate (2017-2022)
Figure Russia Anti-Obesity Prescription Drugs Sales and Growth Rate (2017-2022)
Figure Italy Anti-Obesity Prescription Drugs Sales and Growth Rate (2017-2022)
Figure Spain Anti-Obesity Prescription Drugs Sales and Growth Rate (2017-2022)
Table Europe Anti-Obesity Prescription Drugs Revenue by Manufacturer (2021)
Figure Europe Anti-Obesity Prescription Drugs Revenue Market Share by Manufacturer in 2021
Table Europe Anti-Obesity Prescription Drugs Sales by Type (2017-2022)
Table Europe Anti-Obesity Prescription Drugs Sales Share by Type (2017-2022)
Table Europe Anti-Obesity Prescription Drugs Sales by Application (2017-2022)
Table Europe Anti-Obesity Prescription Drugs Sales Share by Application (2017-2022)
Figure Asia-pacific Anti-Obesity Prescription Drugs Revenue and Growth Rate (2017-2022)
Table Asia-pacific Anti-Obesity Prescription Drugs Sales (Volume) by Countries (2017-2022)
Table Asia-pacific Anti-Obesity Prescription Drugs Sales Market Share by Countries (2017-2022)
Figure Asia-pacific Anti-Obesity Prescription Drugs Sales Market Share by Countries in 2021
Table Asia-pacific Anti-Obesity Prescription Drugs Revenue by Countries (2017-2022)
Table Asia-pacific Anti-Obesity Prescription Drugs Revenue Market Share by Countries (2017-2022)
Figure Asia-pacific Anti-Obesity Prescription Drugs Revenue Market Share by Countries in 2021
Figure China Anti-Obesity Prescription Drugs Sales and Growth Rate (2017-2022)
Figure South Korea Anti-Obesity Prescription Drugs Sales and Growth Rate (2017-2022)
Figure Japan Anti-Obesity Prescription Drugs Sales and Growth Rate (2017-2022)
Figure Australia Anti-Obesity Prescription Drugs Sales and Growth Rate (2017-2022)
Figure India Anti-Obesity Prescription Drugs Sales and Growth Rate (2017-2022)
Figure Southeast Asia Anti-Obesity Prescription Drugs Sales and Growth Rate (2017-2022)
Table Asia-pacific Anti-Obesity Prescription Drugs Revenue by Manufacturer (2021)
Figure Asia-pacific Anti-Obesity Prescription Drugs Revenue Market Share by Manufacturer in 2021
Table Asia-pacific Anti-Obesity Prescription Drugs Sales by Type (2017-2022)
Table Asia-pacific Anti-Obesity Prescription Drugs Sales Share by Type (2017-2022)
Table Asia-pacific Anti-Obesity Prescription Drugs Sales by Application (2017-2022)
Table Asia-pacific Anti-Obesity Prescription Drugs Sales Share by Application (2017-2022)
Figure South America Anti-Obesity Prescription Drugs Revenue and Growth Rate (2017-2022)
Table South America Anti-Obesity Prescription Drugs Sales (Volume) by Countries (2017-2022)
Table South America Anti-Obesity Prescription Drugs Sales Market Share by Countries (2017-2022)
Figure South America Anti-Obesity Prescription Drugs Sales Market Share by Countries in 2019
Table South America Anti-Obesity Prescription Drugs Revenue by Countries (2017-2022)
Table South America Anti-Obesity Prescription Drugs Revenue Market Share by Countries (2017-2022)
Figure South America Anti-Obesity Prescription Drugs Revenue Market Share by Countries in 2019
Figure Brazil Anti-Obesity Prescription Drugs Sales and Growth Rate (2017-2022)
Table South America Anti-Obesity Prescription Drugs Sales by Type (2017-2022)
Table South America Anti-Obesity Prescription Drugs Sales Share by Type (2017-2022)
Table South America Anti-Obesity Prescription Drugs Revenue by Type (2017-2022)
Table South America Anti-Obesity Prescription Drugs Revenue Share by Type (2017-2022)
Table South America Anti-Obesity Prescription Drugs Sales by Application (2017-2022)
Table South America Anti-Obesity Prescription Drugs Sales Share by Application (2017-2022)
Figure Middle East and Africa Anti-Obesity Prescription Drugs Revenue and Growth Rate (2017-2022)
Table Middle East and Africa Anti-Obesity Prescription Drugs Sales (Volume) by Countries (2017-2022)
Table Middle East and Africa Anti-Obesity Prescription Drugs Sales Market Share by Countries (2017-2022)
Figure Middle East and Africa Anti-Obesity Prescription Drugs Sales Market Share by Countries in 2019
Table Middle East and Africa Anti-Obesity Prescription Drugs Revenue by Countries (2017-2022)
Table Middle East and Africa Anti-Obesity Prescription Drugs Revenue Market Share by Countries (2017-2022)
Figure Middle East and Africa Anti-Obesity Prescription Drugs Revenue Market Share by Countries in 2019
Figure GCC Countries Anti-Obesity Prescription Drugs Sales and Growth Rate (2017-2022)
Figure Turkey Anti-Obesity Prescription Drugs Sales and Growth Rate (2017-2022)
Figure Egypt Anti-Obesity Prescription Drugs Sales and Growth Rate (2017-2022)
Figure South Africa Anti-Obesity Prescription Drugs Sales and Growth Rate (2017-2022)
Table Middle East and Africa Anti-Obesity Prescription Drugs Sales by Type (2017-2022)
Table Middle East and Africa Anti-Obesity Prescription Drugs Sales Share by Type (2017-2022)
Table Middle East and Africa Anti-Obesity Prescription Drugs Revenue by Type (2017-2022)
Table Middle East and Africa Anti-Obesity Prescription Drugs Revenue Share by Type (2017-2022)
Table Middle East and Africa Anti-Obesity Prescription Drugs Sales by Application (2017-2022)
Table Middle East and Africa Anti-Obesity Prescription Drugs Sales Share by Application (2017-2022)
Table Global Anti-Obesity Prescription Drugs Sales by Type (2017-2022)
Table Global Anti-Obesity Prescription Drugs Sales Market Share by Type (2017-2022)
Figure Global Anti-Obesity Prescription Drugs Sales Market Share by Type in 2021
Table Global Anti-Obesity Prescription Drugs Revenue by Type (2017-2022)
Table Global Anti-Obesity Prescription Drugs Revenue Market Share by Type (2017-2022)
Figure Global Anti-Obesity Prescription Drugs Revenue Market Share by Type in 2019
Figure Global Orlistat Sales Growth Rate (2017-2022)
Figure Global Orlistat Price (2017-2022)
Figure Global Phentermine and Topiramate Sales Growth Rate (2017-2022)
Figure Global Phentermine and Topiramate Price (2017-2022)
Figure Global Bupropion and Naltrexone Sales Growth Rate (2017-2022)
Figure Global Bupropion and Naltrexone Price (2017-2022)
Figure Global Lorcaserin Sales Growth Rate (2017-2022)
Figure Global Lorcaserin Price (2017-2022)
Figure Global Liraglutide Sales Growth Rate (2017-2022)
Figure Global Liraglutide Price (2017-2022)
Table Global Anti-Obesity Prescription Drugs Sales by Application (2017-2022)
Table Global Anti-Obesity Prescription Drugs Sales Market Share by Application (2017-2022)
Figure Global Anti-Obesity Prescription Drugs Sales Market Share by Application in 2021
Figure Global Pediatric Sales Growth Rate (2017-2022)
Figure Global Adult Sales Growth Rate (2017-2022)
Figure Global Anti-Obesity Prescription Drugs Sales and Growth Rate (2022-2027)
Figure Global Anti-Obesity Prescription Drugs Revenue and Growth Rate (2022-2027)
Table Global Anti-Obesity Prescription Drugs Sales Forecast by Regions (2017-2022)
Table Global Anti-Obesity Prescription Drugs Market Share Forecast by Regions (2017-2022)
Figure North America Sales Anti-Obesity Prescription Drugs Market Forecast (2022-2027)
Figure Europe Sales Anti-Obesity Prescription Drugs Market Forecast (2022-2027)
Figure Asia-Pacific Sales Anti-Obesity Prescription Drugs Market Forecast (2022-2027)
Figure South America Sales Anti-Obesity Prescription Drugs Market Forecast (2022-2027)
Figure Middle East & Africa Sales Anti-Obesity Prescription Drugs Market Forecast (2022-2027)
Table Global Anti-Obesity Prescription Drugs Sales Forecast by Type (2022-2027)
Table Global Anti-Obesity Prescription Drugs Market Share Forecast by Type (2022-2027)
Table Global Anti-Obesity Prescription Drugs Sales Forecast by Application (2022-2027)
Table Global Anti-Obesity Prescription Drugs Market Share Forecast by Application (2022-2027)
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Figure Porter's Five Forces Analysis
Table Macro Analysis of Upstream Markets
Table Key Players in Upstream Markets
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Anti-Obesity Prescription Drugs
Table Macro Analysis of Down Markets
Table Key Players in Down Markets
Table Key Players of Downstream Markets
Figure Sales Channel
Figure Author List

F Hoffmann La Roche Ltd
Alizyme
Arena Pharmaceuticals
Orexigen Therapeutics
Boehringer Ingelheim
Novo Nordisk A/s
Vivus
Glaxosmithkline

First Name *

Last Name

Country *

E-mail *

Contact No *

Company Name*

Job Title*

Comments

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Have a Question?

EMAIL US

RELATED PRODUCTS

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

View All New Reports

Global Freckle-removing Medical and Beau.. The global market for Freckle-removing Medical and Beauty Eq..

Global Wall Mounted Sinks Market Growth .. The sink is a trough-shaped appliance used to receive kitche..

Global Peripheral Imaging Catheter Marke.. The Peripheral Imaging Catheter's unique design provides exc..

Global Hemostatic Valves and Accessories.. Haemostatic valve prevents blood reflux when a catheter is i..

Global Liver Cancer Treatment Drug Marke.. The global market for Liver Cancer Treatment Drug is estimat..

Global Hypertensive Heart Disease Drug M.. The global market for Hypertensive Heart Disease Drug is est..

Global Urinary Incontinence Drug Market .. The global market for Urinary Incontinence Drug is estimated..

Global Pet Antibiotic Market Growth 2022.. The global market for Pet Antibiotic is estimated to increas..

Global Hemorrhagic Disease Detection Mar.. The global market for Hemorrhagic Disease Detection is estim..

Global Cell Dissociation Solution Market.. The global market for Cell Dissociation Solution is estimate..

Global Cell Detachment and Dissociation .. The global market for Cell Detachment and Dissociation Solut..

Global Cell Detachment Solution Market G.. The global market for Cell Detachment Solution is estimated ..

CUSTOM RESEARCH

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

LEARN MORE